New Testosterone Replacement Therapy Offers Novel Delivery System For Men With Low Testosterone
27 October 2003 - 7:45PM
PR Newswire (US)
New Testosterone Replacement Therapy Offers Novel Delivery System
For Men With Low Testosterone NEW YORK, Oct. 27 /PRNewswire/ -- A
new survey of more than 1,000 men ages 40 and older conducted by
the Men's Health Network found that many experience typical
symptoms of a medical condition called hypogonadism, a low level or
absence of testosterone. Symptoms include diminished sexual
interest, depression and changes in physical appearance. Yet nearly
half of the men surveyed were not aware that hypogonadism is a
medical condition, and only five percent had been diagnosed. Now,
the four to five million men with hypogonadism have a new treatment
option. The FDA recently approved a new and unique testosterone
delivery system called Striant Testosterone Buccal System. The
tablet-like product is applied to the upper gum area of the mouth
where it absorbs moisture, softens, and then molds to the shape of
the gum. It provides controlled and sustained release of
testosterone that is absorbed directly into the bloodstream.
ADDITIONAL RESOURCES: Video version and more available at
http://www.prnewswire.com/broadcast/10787/10787_consumer.html
Soundbites: * Christina Wang, MD, Professor of Medicine, Research
and Education Institute at Harbor-UCLA Medical Center * Mort,
Hypogonadism Patient VIDEO PROVIDED BY: COLUMBIA LABORATORIES
DATASOURCE: Columbia Laboratories Contact: MultiVu Media Relations,
+1-800-653-5313, ext. 3, for Columbia Laboratories
Copyright